In Vitro Fertilization (IVF) Market Size to Reach $1036.7

NEW YORK, United States, September 17, 2022 (Globe Newswire) — Facts and Factors has published a new research report titled “In Vitro Fertilization (IVF) Market by Type (Conventional IVF, IVF with ICSI, IVF with Donor Eggs, others), By Cycle (Fresh Non-Donor IVF Cycle, Frozen Non-Donor IVF Cycle, Frozen Donor IVF Cycle, Fresh Donor IVF Cycle), By Product (Equipment, Sperm Analyzer System, Imaging System, Ovum Aspiration Pump, Micromanipulator System, Incubator, Gas Analyzer, Laser System, Cryosystem, Sperm Separation Equipment, IVF Cabinet, Anti-Vibration Table, Witness System, Other equipment, reagents and media, cryopreservation media, embryo culture media, ovum processing media, sperm processing media, accessories), by end user (fertility clinic, hospital and surgical center, cryobank, research institute), and by region – global and Regional industry overview, market intelligence, comprehensive analysis, historical data and forecast 2022–2028. in your research database.

,Global In Vitro Fertilization (IVF) Market It was valued at around USD 628.50 million in 2021 and is projected to grow to around USD 1,0366.7 million by 2028 with a Compound Annual Growth Rate (CAGR) of about 8.7% over the forecast period.

The report analyzes the drivers, constraints/challenges of the In Vitro Fertilization (IVF) market and their impact on demands across the launch period. Furthermore, the report explores the emerging trends and opportunities in the In Vitro Fertilization (IVF) market.

IVF Industry Summary:

In Vitro Fertilization (IVF) enables reproductive technology to be applied in real life and helps couples conceive children who have complications doing so in a natural way. Increasingly sedentary lifestyle and improper habits have increased impotence and other fertility issues across the world and hence fueled the demand for In Vitro Fertilization (IVF) which are advanced fertility clinics capable of treating fertility issues.

Rising popularity of in vitro fertilization (IVF), increasing availability of in vitro fertilization (IVF) procedures, and rising healthcare costs are expected to be the major trends in the growth of the in vitro fertilization (IVF) market during the forecast period. However, the high cost associated with these procedures will have a restraining effect on the growth of the in vitro fertilization (IVF) market.

Click here to access Free Sample Report of the Global In Vitro Fertilization (IVF) Market @

industry growth driver

Increase in average age of first time mothers

The increasing growth of the human population has bought the average age of first-time mothers into significantly higher numbers, as an increasing number of women prefer late marriages and choose careers over family planning, contrary to past trends. Effective use of contraceptives has also played a significant role in shaping the average age trend of first time mothers and is expected to majorly drive the growth of the In Vitro Fertilization (IVF) market over the forecast period.


High Cost of In Vitro Fertilization (IVF) Procedure

In vitro fertilization (IVF) procedures are considered costly across the globe and this is the major factor that will hinder the potential of in vitro fertilization (IVF) market in the forecast period. Lack of insurance coverage makes this situation worse in healthcare countries and irregularities in reimbursement of these procedures also have an overall impact on the growth of the in vitro fertilization (IVF) market.

Buy a copy of the report directly with TOC@

spring Insights

The global In Vitro Fertilization (IVF) market is segmented on the basis of type, cycle, product, end use, and region.

By end-user, the in vitro fertilization (IVF) market has been segmented into fertility clinics, hospitals and surgical centers, cryobanks, and research institutes. The fertility clinics segment will have a bright outlook on the forecast as governments across the world focus on setting up these clinics to boost birth rates, ensure public health and fertility awareness.

The global In Vitro Fertilization (IVF) market is segmented as follows:

by type

  • traditional ivf
  • IVF with ICSI
  • IVF with Donor Eggs
  • other

by bicycle

  • fresh non-donor ivf cycle
  • frozen non-donor ivf cycles
  • frozen donor ivf cycle
  • fresh donor ivf cycle

by product

  • Device
  • sperm analyzer system
  • imaging system
  • Ovum Aspiration Pump
  • micromanipulator system
  • incubator
  • gas analyzer
  • laser system
  • cryosystems
  • sperm separation equipment
  • ivf cabinet
  • Anti-Vibration Tables
  • witness system
  • Other equipment
  • reagents and media
  • cryopreservation media
  • embryo culture media
  • Ovum Processing Media
  • sperm processing media
  • Belongings

by end user

  • fertility clinic
  • Hospitals and Surgical Centers
  • cryobank
  • research institutes

browse full “In Vitro Fertilization (IVF) Market – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data & Forecast 2022-2028” report on

competitive landscape

Some of the main competitors dominating the global In Vitro Fertilization (IVF) market include –

Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Xenia Limited (Australia), IVFTech APS (Denmark), Fujifilm Irvine Scientific (US), The Baker Company, Inc. (US), Kitajato Corporation (Japan), Rocket Medical Plc (UK), Hamilton Thorn Ltd. (US), ZEISS Group (Germany), FERTIPRO NV (Belgium), and Gynotec BV (Netherlands), among others.

Key insights from primary research,

  • As per the analysis, the In Vitro Fertilization (IVF) market is expected to grow at a CAGR of around 8.7% during 2022-2028.
  • In terms of revenue, the size of the in vitro fertilization (IVF) market was estimated to be approximately US$628.50 million in 2021 and is projected to reach US$1,036.7 million by 2028.
  • The fertility clinic segment is anticipated to have a favorable outlook over the projected period.
  • The fresh non-donor segment is projected to account for a major market share and is anticipated to be a dominant segment during the forecast period.
  • In the Asia-Pacific region, the market for in vitro fertilization (IVF) is expected to witness a dominant outlook during the anticipated period.

Request for customization on this report as per your requirements –

regional insight

Asia Pacific will be the most lucrative market for the in vitro fertilization (IVF) industry as predicted and this trend is expected to be driven by several factors. The increasing availability and popularity of In Vitro Fertilization (IVF) procedures and increasing preference of couples to adopt such procedures will be the key trends that will propel the growth of In Vitro Fertilization (IVF) market in the region over the forecast period. India and China are expected to be at the fore of the growth curve in this region by 2028. Growth in medical tourism, increasing number of in vitro fertilization (IVF) centres, increased focus on fertility, adoption of reproductive technology and rising healthcare costs. There are expected to be other key trends affecting the growth of In Vitro Fertilization (IVF) market over the forecast period.

by region

  • North America
    • We
    • Canada
    • rest of north america
  • Europe
    • France
    • UK
    • Spain
    • Germany
    • Italy
    • rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • rest of asia pacific
  • Middle East and Africa
    • Saudi Arab
    • South Africa
    • Rest of Middle East and Africa
  • Latin America
    • Brazil
    • Argentina
    • rest of latin america

recent developments

In 2021 – CooperSurgical and Vertus Health announce the launch of a new partnership that aims to strengthen their reproductive technology and increase access to infertile couples around the world.

scope of report

report attribute description
Market Size (2021) USD 628.50 million
Future Size of the Market (2028) USD 1,036.7 million
CAGR Growth Rate (%) 8.7% CAGR
base year 2021
forecast period 2022-2028
major seller Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Xenia Limited (Australia), IVFtechApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitajato Corporation (Japan), Rocket Medical plc (UK), Hamilton Thorne Ltd (USA), ZEISS Group (Germany), FERTIPRO NV (Belgium), and Gynotec BV (Netherlands), among others
major section By type, cycle, product, end user and region
key areas North America, Europe, Asia Pacific, Latin America and the Middle East & Africa

Browse other related research reports by Facts & Factors:

Global Protein Expression Market Shares likely to grow at a CAGR value of 12.70% by 2028:

Global Donor Egg IVF Services Market Shares likely to grow at a CAGR value of 24.10% by 2028:

Global Telehealth for the Women’s Reproductive and Sexual Health Market Shares likely to grow at a CAGR value of 16.20% by 2028:

Global Medical Transportation Services Market Likely to grow at a CAGR value of 4.50% by 2028:

global neuroscience market Likely to grow at a CAGR value of 3.50% by 2028:

Global Clinical Decision Support System Market Share Expected to grow at around 11.9% CAGR value by 2028:

About facts and factors:

Facts & Factors is a leading market research organization that provides clients with industry expertise and in-depth consulting services for the growth of their business. The reports and services offered by Facts & Factors are used by globally reputed educational institutions, start-ups and companies to measure and understand the changing international and regional business background.


facts and factors

America: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 1999

E-mail: , Web:

What should I follow – linkedin , Twitter , Facebook

Be the first to comment

Leave a Reply

Your email address will not be published.